Alzheimer's Disease as a Membrane Dysfunction Tauopathy? New Insights into the Amyloid Cascade Hypothesis

被引:0
|
作者
Olejar, Tomas [1 ,2 ,3 ,4 ]
Jankovska, Nikol [1 ,2 ,3 ,4 ]
Matej, Radoslav [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Charles Univ Prague, Thomayer Univ Hosp, Fac Med 3, Dept Pathol & Mol Med, Prague 14000, Czech Republic
[2] Thomayer Fac Hosp, Prague 14059, Czech Republic
[3] Charles Univ Prague, Fac Med 3, Dept Pathol, Prague 10034, Czech Republic
[4] Univ Hosp Kralovske Vinohrady, Prague 10034, Czech Republic
[5] Charles Univ Prague, Fac Med 1, Dept Pathol, Prague 12800, Czech Republic
[6] Gen Univ Hosp, Prague 12800, Czech Republic
关键词
Alzheimer's disease; tauopathy; amyloid beta; membrane dysfunction; BETA-PROTEIN; APOLIPOPROTEIN-E; A-BETA; NEURODEGENERATION; PATHOGENESIS; CLEARANCE; OLIGOMERS; PLAQUES; MODEL; TAU;
D O I
10.3390/ijms25179689
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amyloid cascade hypothesis postulates that extracellular deposits of amyloid beta (A beta) are the primary and initial cause leading to the full development of Alzheimer's disease (AD) with intracellular neurofibrillary tangles; however, the details of this mechanism have not been fully described until now. Our preliminary data, coming from our day-to-day neuropathology practice, show that the primary location of the hyperphosphorylated tau protein is in the vicinity of the cell membrane of dystrophic neurites. This observation inspired us to formulate a hypothesis that presumes an interaction between low-density lipoprotein receptor-related protein 1 (LRP1) and fibrillar aggregates of, particularly, A beta(42) anchored at the periphery of neuritic plaques, making internalization of the LRP1-A beta(42) complex infeasible and, thus, causing membrane dysfunction, leading to the tauopathy characterized by intracellular accumulation and hyperphosphorylation of the tau protein. Understanding AD as a membrane dysfunction tauopathy may draw attention to new treatment approaches not only targeting A beta(42) production but also, perhaps paradoxically, preventing the formation of LRP1-A beta(42).
引用
收藏
页数:9
相关论文
共 50 条
  • [31] The phosphorylation cascade hypothesis of Alzheimer's disease
    Brinkmalm, Gunnar
    Zetterberg, Henrik
    NATURE AGING, 2021, 1 (06): : 498 - 499
  • [32] The Alzheimer's Disease Mitochondrial Cascade Hypothesis
    Swerdlow, Russell H.
    Burns, Jeffrey M.
    Khan, Shaharyar M.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 : S265 - S279
  • [33] The phosphorylation cascade hypothesis of Alzheimer’s disease
    Gunnar Brinkmalm
    Henrik Zetterberg
    Nature Aging, 2021, 1 : 498 - 499
  • [34] Solanezumab and the amyloid hypothesis for Alzheimer's disease
    Le, David G.
    Hunter, Sally
    Brayne, Carol
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 355
  • [35] Amyloid-β hypothesis of Alzheimer's disease
    Shearman, MS
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 187 - 190
  • [36] Alzheimer's disease: the amyloid hypothesis on trial
    Harrison, Judith R.
    Owen, Michael J.
    BRITISH JOURNAL OF PSYCHIATRY, 2016, 208 (01) : 1 - 3
  • [37] Alzheimer's Disease, Cerebrovascular Disease, and the β-amyloid Cascade
    Honjo, Kie
    Black, Sandra E.
    Verhoeff, Nicolaas P. L. G.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2012, 39 (06) : 712 - 728
  • [38] Understanding the Amyloid Hypothesis in Alzheimer's Disease
    Paroni, Giulia
    Bisceglia, Paola
    Seripa, Davide
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (02) : 493 - 510
  • [39] Amyloid-β in Alzheimer's Disease: A Study of Citation Practices of the Amyloid Cascade Hypothesis Between 1992 and 2019
    Daly, Timothy
    Houot, Marion
    Barberousse, Anouk
    Agid, Yves
    Epelbaum, Stephane
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 74 (04) : 1309 - 1317
  • [40] Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
    Kametani, Fuyuki
    Hasegawa, Masato
    FRONTIERS IN NEUROSCIENCE, 2018, 12